Get the SPI Wire

aTyr Pharma, Inc.

NASDAQ:ATYR
Annual Meeting

of Shareholders

MEETING DATE

10/16/2026
DEF 14A FILED
09/11/2026
PUBLISHED
09/11/2026 8:06 pm
TIME TO PUBLISH
09/13/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:ATYR · CUSIP 002120202 · CLASS common stock · CIK 0001339970

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

0
FOR
1
AGAINST
0
WITHHOLD
1
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To approve a series of alternate amendments to our restated certificate of incorporation to effect, at the option of our Board of Directors, a reverse stock split of our common stock at a ratio between 1-for-10 and 1-for-50, inclusive, as determined by our Board of Directors in its sole discretion.
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states added available shares could be used to delay or prevent changes in control.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

6c19fb19d623e6448b90f2e44864065e48be39f440387bb87425e0c29e7c2efd

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates